The review found no eligible studies for this question.
Paroxetine showed no clear difference in failure to complete ‐ any cause ‐ compared with citalopram (moderate certainty).
Paroxetine showed no clear difference in participants with at least some Side Effects compared with citalopram (moderate certainty).
Paroxetine showed no clear difference in failure to respond at endpoint (6‐12 weeks) compared with escitalopram (moderate certainty).
Paroxetine showed no clear difference in failure to respond at 16‐24 weeks compared with escitalopram (moderate certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with escitalopram (low certainty).
Paroxetine showed no clear difference in failure to complete ‐ any cause ‐ compared with escitalopram (moderate certainty).
Paroxetine showed no clear difference in participants with at least some Side Effects compared with escitalopram (moderate certainty).
It is very uncertain whether fluoxetine changes failure to respond (reduction ≥ 50% on HDRS) compared with citalopram (very low certainty).
Fluoxetine showed no clear difference in failure to complete ‐ total ‐ compared with citalopram (moderate certainty).
Fluoxetine showed no clear difference in failure to complete ‐ inefficacy ‐ compared with citalopram (moderate certainty).
Fluoxetine showed no clear difference in failure to complete ‐ side effects ‐ compared with citalopram (moderate certainty).
Fluoxetine showed no clear difference in failure to respond (reduction ≥ 50% on HDRS) compared with escitalopram (low certainty).
Fluoxetine showed no clear difference in failure to complete ‐ total ‐ compared with escitalopram (moderate certainty).